CytoMed Therapeutics Ltd Files 20-F for FY2024
Ticker: GDTC · Form: 20-F · Filed: Apr 28, 2025 · CIK: 1873093
| Field | Detail |
|---|---|
| Company | Cytomed Therapeutics LTD (GDTC) |
| Form Type | 20-F |
| Filed Date | Apr 28, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: annual-report, sec-filing, pharmaceuticals
TL;DR
CytoMed Therapeutics filed its 20-F for 2024, check financials.
AI Summary
CytoMed Therapeutics Ltd filed its 20-F report for the fiscal year ending December 31, 2024. The company, previously known as CytoMed Therapeutics Pte. Ltd. until July 16, 2021, is based at #08-22 One Commonwealth, Singapore. The filing covers financial data and business operations for the period.
Why It Matters
This filing provides investors with a comprehensive overview of CytoMed Therapeutics' financial health and business activities for the past fiscal year, crucial for investment decisions.
Risk Assessment
Risk Level: low — The filing is a standard annual report (20-F) and does not contain immediate red flags or significant new disclosures that would indicate a high risk.
Key Numbers
- 2024-12-31 — Fiscal Year End (The reporting period covered by the 20-F filing.)
- 20250428 — Filing Date (The date the 20-F report was submitted to the SEC.)
- 001-41677 — SEC File Number (Unique identifier for the company's filings with the SEC.)
Key Players & Entities
- CytoMed Therapeutics Ltd (company) — Filer of the 20-F report
- CytoMed Therapeutics Pte. Ltd. (company) — Former name of the company
- 2024-12-31 (date) — Fiscal year end
- 20250428 (date) — Filing date
- 001-41677 (dollar_amount) — SEC File Number
FAQ
What is the primary business of CytoMed Therapeutics Ltd?
CytoMed Therapeutics Ltd is classified under 'Pharmaceutical Preparations' (SIC code 2834).
When did CytoMed Therapeutics Ltd change its name?
The company changed its name from CytoMed Therapeutics Pte. Ltd. on July 16, 2021.
What is the business address of CytoMed Therapeutics Ltd?
The business address is #08-22 One Commonwealth, 1 Commonwealth Lane, Singapore, 149544.
What fiscal year does this 20-F report cover?
This 20-F report covers the fiscal year ending December 31, 2024.
What is the SEC file number for CytoMed Therapeutics Ltd?
The SEC file number for CytoMed Therapeutics Ltd is 001-41677.
Filing Details
This Form 20-F (Form 20-F) was filed with the SEC on April 28, 2025 regarding CytoMed Therapeutics Ltd (GDTC).